Suppr超能文献

用于口服递送羟基-α-山嵛菜碱的海藻酸钠/壳聚糖包衣脂质体:体外和体内评价

Sodium Alginate/Chitosan-Coated Liposomes for Oral Delivery of Hydroxy-α-Sanshool: In Vitro and In Vivo Evaluation.

作者信息

Tan Fengming, Li Huan, Zhang Kai, Xu Lulu, Zhang Dahan, Han Yang, Han Jing

机构信息

Department of Pharmaceutical Engineering, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China.

School of Chinese Materia Medica, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China.

出版信息

Pharmaceutics. 2023 Jul 24;15(7):2010. doi: 10.3390/pharmaceutics15072010.

Abstract

BACKGROUND

Hydroxy-α-Sanshool (HAS) possesses various pharmacological properties, such as analgesia and regulating gastrointestinal function. However, the low oral bioavailability of HAS has limited its oral delivery in clinical application.

METHODS AND RESULTS

To enhance its oral bioavailability, a nanocomposite delivery system based on chitosan (CH, as the polycation) and sodium alginate (SA, as the polyanion) was prepared using a layer-by-layer coating technique. The morphology, thermal behavior and Fourier transform infrared spectrum (FTIR) showed that the obtained sodium alginate/chitosan-coated HAS-loaded liposomes (SA/CH-HAS-LIP) with core-shell structures have been successfully covered with polymers. When compared with HAS-loaded liposomes (HAS-LIP), SA/CH-HAS-LIP displayed obvious pH sensitivity and a sustained-release behavior in in vitro studies, which fitted well to Weibull model. In vivo, the half-life of HAS from SA/CH-HAS-LIP remarkably extended after oral administration compared to the free drug. Additionally, it allowed a 4.6-fold and 4.2-fold increase in oral bioavailability, respectively, compared with free HAS and HAS-LIP.

CONCLUSIONS

SA/CH-HAS-LIP could be a promising release vehicle for the oral delivery of HAS to increase its oral bioavailability.

摘要

背景

羟基-α-山椒素(HAS)具有多种药理特性,如镇痛和调节胃肠功能。然而,HAS口服生物利用度低限制了其在临床应用中的口服给药。

方法与结果

为提高其口服生物利用度,采用层层包覆技术制备了一种基于壳聚糖(CH,作为聚阳离子)和海藻酸钠(SA,作为聚阴离子)的纳米复合递送系统。形态学、热行为和傅里叶变换红外光谱(FTIR)表明,所制备的具有核壳结构的海藻酸钠/壳聚糖包覆载HAS脂质体(SA/CH-HAS-LIP)已成功被聚合物包覆。与载HAS脂质体(HAS-LIP)相比,SA/CH-HAS-LIP在体外研究中表现出明显的pH敏感性和缓释行为,与韦布尔模型拟合良好。在体内,口服给药后,SA/CH-HAS-LIP中HAS的半衰期相比游离药物显著延长。此外,与游离HAS和HAS-LIP相比,其口服生物利用度分别提高了4.6倍和4.2倍。

结论

SA/CH-HAS-LIP可能是一种有前景的HAS口服递送载体,可提高其口服生物利用度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4f/10383520/1f2661746a6c/pharmaceutics-15-02010-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验